Community pharmacistephysician collaborative streptococcal pharyngitis management program

Journal of the American Pharmacists Association

Volumn 56, Issue 3, 2016, Pages 323-329.e1

  Klepser, Donald G ^a   Klepser, Michael E ^b   Dering Anderson, Allison M ^a   Morse, Jacqueline A ^c   Smith, Jaclyn K ^a   Klepser, Stephanie A ^d  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b FERRIS STATE UNIVERSITY   (United States)

^c Meijer Pharmacy ^*  (United States)

^d OptiMed Pharmacy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ANTIGEN DETECTION; CONFERENCE PAPER; FEASIBILITY STUDY; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHARMACIST; PHYSICIAN; PROSPECTIVE STUDY; STREPTOCOCCAL PHARYNGITIS; CLINICAL TRIAL; COOPERATION; FEMALE; MALE; ORGANIZATION AND MANAGEMENT; PATIENT REFERRAL; PHARMACY; PHARYNGITIS; STREPTOCOCCAL INFECTIONS; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; COMMUNITY PHARMACY SERVICES; COOPERATIVE BEHAVIOR; FEMALE; HUMANS; MALE; PHARMACISTS; PHARYNGITIS; PHYSICIANS; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; STREPTOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 84969141655     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1016/j.japh.2015.11.013     Document Type: Article

References (37)

1. Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2006. National Health Statistics Reports; no 8. Hyattsville, MD: National Center for Health Statistics; 2008.
2. Bisno AL. Primary care: acute pharyngitis. N Engl J Med. 2001;344: 205-211.
3. Komaroff AL, Pass TM, Aronson MD, et al. The prediction of streptococcal pharyngitis in adults. J Gen Intern Med. 1986;1:1-7.
4. Linder JA, Chan J, Bates DW. Evaluation and treatment of pharyngitis in primary care practice: the difference between guidelines is largely academic. Arch Intern Med. 2006;166:1374-1379.
5. Ladd E. The use of antibiotics for viral upper respiratory tract infections: an analysis of nurse practitioner and physician prescribing practices in ambulatory care, 1997-2001. J Am Acad Nurse Pract. 2005;17:416-424.
6. Linder JA, Stafford RS. Antibiotic treatment of adults with sore throat by community care physicians: a national survey, 1989-1999. JAMA. 2001;286:1181-1186.
7. Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the IDSA. Clin Infect Dis. 2012;55(10):e86-e102.
8. Howard DH, Scott RD. The economic burden of drug resistance. Clin Infect Dis. 2005;41(suppl. 4):S283-S286.
9. Tleyjeh IM, Tlaygeh HM, Hejal R, et al. The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis. Clin Infect Dis. 2006;42:788-797.
10. Rubin RJ, Harrington CA, Poon A, et al. The economic impact of Staphy-lococcus aureus infection in New York City Hospitals. Emerg Infect Dis. 1999;5:9.
11. Centor RM, Witherspoon JM, Dalton HP, et al. The diagnosis of strep throat in adults in the emergency room. Med Decis Making. 1981;1(3):239-246.
12. McIsaac WJ, Goel V, To T, Low DE. The validity of a sore throat score in family practice. CMAJ. 2000;163(7):811-815.
13. McKnight AG, Thomason AR. Pharmacists' advancing roles in drug and disease management: a review of states' legislation. J Am Pharm Assoc. 2008;49:554-558.
14. Gubbins PO, Klepser ME, Dering-Anderson MA, et al. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy. J Am Pharm Assoc. 2014;54:163-171.
15. Klepser ME, Klepser DE, Dering-Anderson AM, et al. Effectiveness of pharmacist-physician collaborative program to manage influenza-like illness. J Am Pharm Assoc. 2016;56(1):14-21.
16. National Association of Chain Drug Stores. Community pharmacyebased point-of-care testing certificate program. Available at: http://nacds. learnercommunity.com/course-information. Accessed June 1, 2015.
17. Klepser ME, Adams AJ, Klepser DG. Antimicrobial stewardship in outpatient settings: leveraging innovative physician-pharmacist collaborations to reduce antibiotic resistance. Health Security. 2015;13(3):166-173.
18. Quidel Corporation. QuickVue strep A test package insert. Available at: http://www.quidel.com/sites/default/files/product/documents/quickvue plusstrepa.pdf. Accessed June 1, 2015.
19. Accreditation Council for Pharmacy Education. Accreditation standards and guidelines: Standards 2016. Available at: https://www.acpe-accredit. org/pdf/Standards2016FINAL.pdf. Accessed May 15, 2015.
20. National Association of Boards of Pharmacy. NAPLEX Blueprint 2015. Available at: http://www.nabp.net/programs/examination/naplex/naplex-blueprint#revised. Accessed June 17, 2015.
21. Hogue MD, Grabenstein JD, Foster SL, Rothholz MC. Pharmacist involvement with immunizations: a decade of professional advancement. J Am Pharm Assoc. 2006;46:168-179.
22. Weitzel KW, Goode JV. Implementation of a pharmacy-based immunization program in a supermarket chain. J Am Pharm Assoc. 2000;40: 252-256.
23. Dent LA, Harris KJ, Noonan CW. Tobacco interventions delivered by pharmacists: a summary and systematic review. Pharmacotherapy. 2007;27:1040-1051.
24. Elias MN, Burden AM, Cadarette SM. The impact of pharmacist interventions on osteoporosis management: a systematic review. Osteoporosis Int. 2011;22:2587-2596.
25. Snella KA, Canales AE, Irons BK, et al. Pharmacy-and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals. J Am Pharm Assoc. 2006;46:370-377.
26. Kauffman Y, Nair V, Herist K, Thomas V, Weidle PJ. HIV medication therapy management services in community pharmacies. J Am Pharm Assoc. 2012;52:e287-e291.
27. Kuehn BM. CDC pilot program will offer free rapid HIV tests through pharmacies. JAMA. 2012;308:327.
28. Dering-Anderson A, Kilgore P, Hospodka R, Akinwale T. Creating a pharmacist's clinical collaborative practice agreement. Pharmacy tool kit. Available at: http://www.naccho.org/toolbox/tool.cfm?id=4515. Accessed March 4, 2015.
29. Shapiro DJ, Hicks LA, Pavia AT, Hersh AL. Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. J Antimicrob Chemother. 2014;69(1):234-240.
30. Klepser DG, Bisanz SE, Klepser ME. Cost-effectiveness of pharmacist-provided treatment of adult pharyngitis. Am J Manag Care. 2012;18: e145-e154.
31. Berry LL, Mirabito AM. Innovative healthcare delivery. Bus Horiz. 2010;53(2):157-169.
32. Department of Health and Human Services. The adequacy of pharmacist supply: 2004-2030. Available at: http://bhpr.hrsa.gov/healthworkforce/reports/pharmsupply20042030.pdf. Accessed April 19, 2015.
33. Klepser DG, Dering-Anderson AM, Morse JA, et al. Time and motion study of influenza diagnostic testing in a community pharmacy. Innov Pharm. 2014;5(2):159.
34. Corn C, Klepser DG, Dering-Anderson AM. Observation of pharmacist conducted strep point-of-care testing: a time and motion study. Poster presented at APhA Annual Meeting, San Diego, CA, March 2015.
35. Barnett ML, Linder JA. Antibiotic prescribing to adults with sore throat in the United States, 1997-2010. JAMA Intern Med. 2014;174(1):138-140.
36. White House. Executive orderecombating antibiotic-resistant bacteria. September 18, 2014. Available at: https://www.whitehouse.gov/the-press-office/2014/09/18/executive-order-combating-antibiotic-resistant-bacteria. Accessed June 22, 2015.
37. White House. National strategy for combating antibiotic-resistant bacteria. September 2014. Available at: https://www.whitehouse.gov/sites/default/files/docs/carb-national